Market Place
Sourcing Support
Grace Therapeutics Hosts Virtual KOL Event on GTx-104
30 Oct 2024 //
GLOBENEWSWIRE
Acasti Completes Enrollment In GTX-104 Phase 3 STRIVE-ON
25 Sep 2024 //
GLOBENEWSWIRE
Acasti to Present at the Life Sciences Investor Forum
12 Sep 2024 //
GLOBENEWSWIRE
Acasti To Participate In H.C. Wainwright Investment Conference
05 Sep 2024 //
GLOBENEWSWIRE
Annora Pharma`s Generic Nimodipine Receives Approvals in US
09 Jul 2024 //
FDA
Amneal Pharms LLC’s Generic Nimodipine Receives Tentative Approval In US
14 May 2024 //
FDA
Acasti Pharma Reports Fiscal Year 2023 Operational Results
23 Jun 2023 //
PR NEWSWIRE
Acasti Successfully Submits Pivotal GTX-104 Ph 3 Safety Study Protocol with FDA
08 May 2023 //
PR NEWSWIRE
Enforcement Report for Week of October 7, 2020
07 Oct 2020 //
FDA
Arbor Pharmaceuticals, LLC Launches New Nymalize® (nimodipine) Oral Solution
20 Sep 2017 //
PR NEWSWIRE
Oral dosage forms containing nimodipine solid dispersion & hydrophilic carriers
08 Nov 2016 //
PHARMA EXCIPIENTS
Edge Therapeutics swings for a $115M IPO with eyes on Phase III
17 Aug 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.